Cargando…
Progress in CSF biomarker discovery in sCJD
Autores principales: | Llorens, Franc, Schmitz, Matthias, Zerr, Inga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351571/ https://www.ncbi.nlm.nih.gov/pubmed/28086207 http://dx.doi.org/10.18632/oncotarget.13998 |
Ejemplares similares
-
CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD
por: Ermann, Natalia, et al.
Publicado: (2018) -
Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients
por: Douet, Jean-Yves, et al.
Publicado: (2021) -
Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders
por: Singh, Ajay, et al.
Publicado: (2011) -
Ocular Tonometry and Sporadic Creutzfeldt - Jakob Disease (sCJD): A Confirmatory Case-Control Study
por: Davanipour, Zoreh, et al.
Publicado: (2014) -
Epitope mapping of the protease resistant products of RT-QuIC does not allow the discrimination of sCJD subtypes
por: Piconi, Gabriele, et al.
Publicado: (2019)